Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Bristol Myers Squibb Co. (BMY)

Page 1 of 2

You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make proper and accurate analysis of certain small-cap companies. However, well-known and successful hedge fund investors like Carl Icahn and George Soros hold the necessary resources and abilities to conduct an extensive stock analysis on small-cap stocks, which enable them to make millions of dollars by identifying potential winners within the small-cap galaxy of stocks. This represents the main reason why Insider Monkey takes notice of the hedge fund activity in these overlooked stocks.

Bristol Myers Squibb Co. (NYSE:BMY) was in 62 hedge funds’ portfolios at the end of the third quarter of 2015. BMY investors should be aware of an increase in activity from the world’s largest hedge funds lately. There were 48 hedge funds in our database with BMY positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as China Life Insurance Company Ltd. (ADR) (NYSE:LFC), Medtronic, Inc. (NYSE:MDT), and McDonald’s Corporation (NYSE:MCD) to gather more data points.

Follow Bristol Myers Squibb Co (NYSE:BMY)
Trade (NYSE:BMY) Now!

In today’s marketplace there are dozens of metrics investors use to value their stock investments. Two of the less known metrics are hedge fund and insider trading indicators. We have shown that, historically, those who follow the best picks of the elite hedge fund managers can outclass the broader indices by a superb margin (see the details here).

Now, we’re going to view the recent action encompassing Bristol Myers Squibb Co. (NYSE:BMY).

What does the smart money think about Bristol Myers Squibb Co. (NYSE:BMY)?

Heading into Q4, a total of 62 of the hedge funds tracked by Insider Monkey were bullish on this stock, an increase of 29% from the second quarter. With hedgies’ sentiment swirling, there exists a few noteworthy hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Samuel Isaly’s OrbiMed Advisors has the most valuable position in Bristol Myers Squibb Co. (NYSE:BMY), worth close to $513.2 million, corresponding to 5.2% of its total 13F portfolio. The second most bullish fund manager is Ken Griffin of Citadel Investment Group, with a $417.5 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Other peers that are bullish contain Phill Gross and Robert Atchinson’s Adage Capital Management, Clifford Fox’s Columbus Circle Investors and Christopher James’s Partner Fund Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!